
Poster: Semantic-Web Access to Patent Annotations
SWAT4LS International Conference 2015, Cambridge, UK View poster
Conference: CiMUS Innopharma Open Innovation Day
CiMUS Innopharma Open Innovation Day, Santiago de Compostela, Spain Stefan Senger (GlaxoSmithKline) gave a presentation: What is Open PHACTS and why would you care?
Presentation: What is Open PHACTS and why would you care?
CiMUS Innopharma Open Innovation Day, Santiago de Compostela, Spain Stefan Senger (GlaxoSmithKline) View presentation
Publication: Incorporating private and commercial data into an open linked data platform for drug discovery
The Open PHACTS Discovery Platform aims to provide an integrated information space to advance pharmacological research in the area of drug discovery. Effective drug discovery requires comprehensive data coverage, i.e. integrating all available sources of pharmacology data. While many relevant data sources are available on the linked open data cloud,…
Open PHACTS featured in blog posts
Open PHACTS has been featured on the ChEMBL and Corante blogs: ChEMBL blog: Direct submissions of data to ChEMBL and the Open PHACTS project by Stefan Senger Corante blog: In the Pipeline: Why Not Share More Bioactivity Data? by Derek Lowe
Publication: Open data for drug discovery: learning from the biological community
Drug discovery is undergoing a transformational change. Early-stage target identification, lead generation and optimization work is now undertaken in a much more diverse set of organizations, involving biotechnology companies and academia as well as large pharmaceutical companies. Anne Hersey, Stefan Senger, John Overington Full publication: Future Medicinal Chemistry, Volume 4,…